Why India Needs Mandatory Kidney Tests Starting at Age 20: The Parliamentary Committee’s Wake-Up Call
A quiet but urgent warning has come from India’s Parliament. The Department-related Parliamentary Standing Committee on Health and Family Welfare, in its 177th report titled “Prevalence of Chronic Kidney Disease in India – Prevention, Diagnosis, Treatment and Management,” has recommended mandatory kidney function tests every six months for every adult aged 20 years and above. Tabled in both Houses of Parliament on 7 August 2026 and headed by Rajya Sabha MP Ram Gopal Yadav, the report contains 66 recommendations that mark a decisive shift in how the country should approach chronic kidney disease (CKD). Instead of focusing primarily on treating advanced kidney failure through dialysis and transplants, the committee wants the system to prioritise prevention, early detection and slowing disease progression.
The proposal is striking because it expands routine screening to a much younger age group than existing non-communicable disease programmes, which largely target people aged 30 and above. Under the recommendation, these biannual kidney function tests (KFTs) would be free for those below the poverty line and available at a nominal cost for others through the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD). Parallel annual screening is advised for all high-risk individuals.
The Silent Scale of the Problem
CKD has become one of India’s fastest-growing non-communicable diseases. A systematic review cited by the committee estimated the pooled prevalence at about 13.24 per cent based on community studies. Some assessments place the adult burden in the 13–16 per cent range. Prevalence has risen noticeably: from around 11.12 per cent in studies between 2011 and 2017 to 16.38 per cent in more recent data covering 2018–2023 among people aged 15 and above. In 2017 alone, India was estimated to have roughly 115 million cases, forming a substantial share of the global burden alongside China.
What makes CKD particularly dangerous is its silent nature. In the early stages the disease produces few or no symptoms. By the time patients notice swelling, fatigue, changes in urination or other signs, significant and often irreversible loss of kidney function has already occurred. Serum creatinine levels, the most commonly ordered blood test, can remain within the “normal” range even when kidney function has declined substantially. This leads to late diagnosis, higher rates of complications (especially cardiovascular disease, the leading cause of death in CKD patients), and greater dependence on expensive kidney replacement therapy.
The numbers at the end-stage are alarming. Nearly 2.2 lakh new patients with end-stage kidney disease are added every year in India. This creates an additional demand for roughly 3.4 crore dialysis sessions annually. The human and financial cost is enormous, and the system is already under severe strain.
Who Is at Highest Risk
Diabetes and hypertension together account for the majority of CKD cases in the country. Other priority groups identified by the committee include adults above 60 years, people with a family history of kidney disease, those with obesity or tobacco use, individuals with a history of acute kidney injury, recurrent urinary tract infections or kidney stones, and people with prolonged exposure to nephrotoxic medicines, particularly non-steroidal anti-inflammatory drugs (NSAIDs) that are widely available over the counter.
A separate and growing concern is Chronic Kidney Disease of Unknown Etiology (CKDu). This form of the disease is more common among agricultural workers and outdoor labourers in certain regions, including parts of Andhra Pradesh, Odisha and Karnataka. Suspected contributors include chronic heat stress, repeated dehydration, pesticide exposure, contaminated drinking water and heavy metals. The committee has called for focused multidisciplinary research, strengthened surveillance in endemic areas, and occupational health measures such as hydration facilities, shaded rest areas and awareness programmes for farm, construction and factory workers.
The Core Testing Recommendations
The committee’s central proposal is clear: institutionalise regular annual CKD screening for all high-risk individuals and introduce mandatory biannual kidney function tests for every person aged 20 years and above. Screening should include estimated glomerular filtration rate (eGFR) and urine albumin or protein testing, followed by appropriate referral and follow-up.
A practical and potentially transformative recommendation is that every serum creatinine test performed in public or private laboratories should automatically include an eGFR report, preferably calculated using the CKD-EPI equation, without requiring a separate request or extra cost to the patient. Serum creatinine alone is inadequate for early detection; adding eGFR would give clinicians a far better picture of kidney function.
These measures are intended to move detection upstream so that lifestyle changes, better control of blood pressure and blood sugar, and other interventions can delay or prevent progression to kidney failure.
Beyond Testing: A Comprehensive Strategy
The 66 recommendations go well beyond laboratory tests. The committee has urged the Ministry of Health and Family Welfare to treat CKD as a high-priority national health issue and formulate a comprehensive national strategy with clear objectives and measurable outcomes. It has called for a dedicated National CKD Programme (modelled on the successful HIV/AIDS programme) and the establishment of a National CKD Registry to capture real-time data on occurrence, progression, treatment and outcomes — something currently missing.
Other important suggestions include:
- Expanding dialysis services, including free dialysis at Ayushman Arogya Mandirs, and promoting home-based peritoneal dialysis, which remains under-utilised.
- Extending post-transplant coverage under Ayushman Bharat PM-JAY from the current 15 days to a full year, covering follow-up consultations, investigations and immunosuppressive medicines.
- Addressing the severe shortage of nephrologists, urologists and dialysis technicians, especially at district hospitals. In many states there are no sanctioned posts for these specialists. One practical suggestion is to allow physicians with an MD in general medicine who complete one year of specialised training to supervise dialysis units.
- Strengthening regulation and public awareness around the irrational use and over-the-counter availability of nephrotoxic medicines.
- Integrating kidney health education into school curricula and training frontline workers (ASHA workers, Community Health Officers and Medical Officers) in prevention and risk communication, with culturally appropriate materials in regional languages.
- Encouraging research into Ayurvedic approaches and environmental/occupational causes of CKD.
Why the Shift Matters
For years, policy attention and resources have concentrated on expanding dialysis capacity and transplant services. While necessary, this approach treats the end-stage of a disease that is often preventable or manageable if caught early. The committee has argued that without a prevention-first orientation, the future demand for kidney replacement therapy will become unsustainable.
Early detection through systematic screening can reduce complications, improve quality of life, lower long-term costs for families and the health system, and ease pressure on an already overstretched specialised workforce. The inclusion of younger adults (from age 20) recognises that risk factors such as diabetes, hypertension, obesity and environmental exposures are increasingly affecting people earlier in life.
Implementation will require coordination between the Centre and states, adequate funding under NP-NCD, laboratory standardisation, and sustained public awareness. The recommendations are not yet government policy; they form the considered advice of a parliamentary committee. How quickly and fully the Ministry of Health acts on them will determine whether India can reverse the rising trajectory of this silent epidemic.
Chronic kidney disease rarely announces itself until it is advanced. The parliamentary committee’s report is a clear signal that waiting for symptoms is no longer an acceptable strategy. Systematic testing starting in early adulthood, combined with better risk-factor control and targeted protections for vulnerable workers, offers a realistic path to reducing the human and economic toll of a disease that already affects more than one in eight adults in India.
About The Author
